Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD
0.18 (2.20%)
May 20, 2022 4:00 PM EDT - Market closed

Total Valuation

GLUE has a market cap or net worth of $389.68 million. The enterprise value is $74.17 million.

Market Cap389.68M
Enterprise Value74.17M

Important Dates

The latest earnings date was Wednesday, March 30, 2022, before market open.

Last Earnings DateMar 30, 2022
Ex-Dividend Daten/a

Share Statistics

GLUE has 46.67 million shares outstanding. The number of shares has increased by 2,626.13% in one year.

Shares Outstanding46.67M
Shares Change (YoY)+2,626.13%
Shares Change (QoQ)+86.38%
Owned by Insiders (%)0.89%
Owned by Institutions (%)97.21%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio1.20
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 25.65, with a Debt / Equity ratio of 0.02.

Current Ratio25.65
Quick Ratio25.82
Debt / Equity0.02
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -24.50%, which is considered low. The company has a ROIC of -173.80%.

Return on Equity (ROE)-24.50%
Return on Assets (ROA)-23.40%
Return on Capital (ROIC)-173.80%
Revenue Per Employeen/a
Profits Per Employee-$901,200
Employee Count95
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-56.05%
50-Day Moving Average11.44
200-Day Moving Average15.15
Average Volume (30 Days)270,700

Short Selling Information

The latest short interest is 5.66 million, so 12.14% of the outstanding shares have been sold short.

Short Interest5.66M
Short % of Shares Out12.14%
Short % of Float24.52%
Short Ratio (days to cover)36.04

Income Statement

Gross Profitn/a
Operating Income-85.68M
Net Income-85.61M
Earnings Per Share (EPS)-$2.36
Full Income Statement

Balance Sheet

The company has $322.50 million in cash and $6.98 million in debt, giving a net cash position of $315.52 million or $6.76 per share.

Cash & Cash Equivalents322.50M
Total Debt6.98M
Net Cash315.52M
Net Cash Per Share$6.76
Book Value325.88M
Book Value Per Share6.98
Working Capital307.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$72.95 million and capital expenditures -$9.00 million, giving a free cash flow of -$81.95 million.

Operating Cash Flow-72.95M
Capital Expenditures-9.00M
Free Cash Flow-81.95M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

GLUE does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-21.97%
FCF Yield-21.03%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-2,626.13%
Shareholder Yield-2,626.13%
Dividend Details

Analyst Forecast

The average price target for GLUE is $28.27, which is 238.56% higher than the current price. The consensus rating is "Buy".

Price Target$28.27
Price Target Difference238.56%
Analyst ConsensusBuy
Analyst Count14
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a